Ventripoint Diagnostics Ltd. (VPT.V)
- Previous Close
0.1400 - Open
0.1350 - Bid 0.1300 x --
- Ask 0.1350 x --
- Day's Range
0.1350 - 0.1350 - 52 Week Range
0.0800 - 0.2600 - Volume
8,000 - Avg. Volume
267,167 - Market Cap (intraday)
21.576M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0300 - Earnings Date May 28, 2025 - Jun 2, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers. The company also provides VMS+ software, a 2D and 3D ultrasound models. In addition, it develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging, and cardiotoxicity in oncology patients. Ventripoint Diagnostics Ltd. is headquartered in Toronto, Canada.
ventripoint.comRecent News: VPT.V
View MorePerformance Overview: VPT.V
Trailing total returns as of 5/8/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: VPT.V
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: VPT.V
View MoreValuation Measures
Market Cap
22.37M
Enterprise Value
23.71M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
161.10
Price/Book (mrq)
--
Enterprise Value/Revenue
173.57
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-236.18%
Return on Equity (ttm)
--
Revenue (ttm)
95.17k
Net Income Avi to Common (ttm)
-4.92M
Diluted EPS (ttm)
-0.0300
Balance Sheet and Cash Flow
Total Cash (mrq)
60.55k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-2.4M